115 related articles for article (PubMed ID: 15618280)
1. Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats.
Yoshiji H; Noguchi R; Kuriyama S; Ikenaka Y; Yoshii J; Yanase K; Namisaki T; Kitade M; Masaki T; Fukui H
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G907-13. PubMed ID: 15618280
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats.
Yoshiji H; Kuriyama S; Noguchi R; Ikenaka Y; Yoshii J; Yanase K; Namisaki T; Kitade M; Yamazaki M; Asada K; Akahane T; Tsujimoto T; Uemura M; Fukui H
Int J Mol Med; 2006 May; 17(5):899-904. PubMed ID: 16596278
[TBL] [Abstract][Full Text] [Related]
3. Effects of ribozyme targeting platelet-derived growth factor receptor beta subunit gene on the proliferation and apoptosis of hepatic stellate cells in vitro.
Chen YX; Lu CH; Xie WF; Zhang XR; Zhang ZB; Wei LX; Jin YX; Guo YJ
Chin Med J (Engl); 2005 Jun; 118(12):982-8. PubMed ID: 15978205
[TBL] [Abstract][Full Text] [Related]
4. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.
Yasuda Y; Shimizu M; Sakai H; Iwasa J; Kubota M; Adachi S; Osawa Y; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2009 Dec; 182(2-3):159-64. PubMed ID: 19646978
[TBL] [Abstract][Full Text] [Related]
5. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
Gonzalo T; Beljaars L; van de Bovenkamp M; Temming K; van Loenen AM; Reker-Smit C; Meijer DK; Lacombe M; Opdam F; Kéri G; Orfi L; Poelstra K; Kok RJ
J Pharmacol Exp Ther; 2007 Jun; 321(3):856-65. PubMed ID: 17369283
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 2001 Oct; 34(4 Pt 1):745-50. PubMed ID: 11584371
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of platelet derived growth factor and its receptor in liver tissues of patients with liver fibrosis].
Yuan N; Wang P; Wang X; Wang Z
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):58-60. PubMed ID: 11856507
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
9. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice.
Lassila M; Jandeleit-Dahm K; Seah KK; Smith CM; Calkin AC; Allen TJ; Cooper ME
J Am Soc Nephrol; 2005 Feb; 16(2):363-73. PubMed ID: 15625075
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA
Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
[TBL] [Abstract][Full Text] [Related]
12. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
Leipner C; Grün K; Müller A; Buchdunger E; Borsi L; Kosmehl H; Berndt A; Janik T; Uecker A; Kiehntopf M; Böhmer FD
Cardiovasc Res; 2008 Jul; 79(1):118-26. PubMed ID: 18326555
[TBL] [Abstract][Full Text] [Related]
13. Cocktail therapy with a combination of interferon, ribavirin and angiotensin-II type 1 receptor blocker attenuates murine liver fibrosis development.
Yoshiji H; Noguchi R; Ikenaka Y; Kaji K; Aihara Y; Shirai Y; Yoshii J; Yanase K; Fukui H
Int J Mol Med; 2011 Jul; 28(1):81-8. PubMed ID: 21455560
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
[TBL] [Abstract][Full Text] [Related]
15. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1.
Fu Y; Chen A
Biochem Pharmacol; 2006 Jul; 72(2):227-38. PubMed ID: 16750517
[TBL] [Abstract][Full Text] [Related]
16. Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis.
Borkham-Kamphorst E; Stoll D; Gressner AM; Weiskirchen R
Biochem Biophys Res Commun; 2004 Aug; 321(2):413-23. PubMed ID: 15358192
[TBL] [Abstract][Full Text] [Related]
17. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.
Abe W; Ikejima K; Lang T; Okumura K; Enomoto N; Kitamura T; Takei Y; Sato N
J Hepatol; 2007 Feb; 46(2):286-94. PubMed ID: 17166617
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effect of salvianolic acid A on rat hepatic stellate cells.
Lin YL; Lee TF; Huang YJ; Huang YT
J Pharm Pharmacol; 2006 Jul; 58(7):933-9. PubMed ID: 16805953
[TBL] [Abstract][Full Text] [Related]
20. Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term.
Neef M; Ledermann M; Saegesser H; Schneider V; Widmer N; Decosterd LA; Rochat B; Reichen J
J Hepatol; 2006 Jan; 44(1):167-75. PubMed ID: 16168515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
